Annual HIV prevention injection passes early safety trial
Zuko Komisa Image | Adobe Stock A potential game-changer in the fight against HIV has emerged, as early safety trials for a revolutionary annual injection have yielded positive results. The drug, lenacapavir, designed to prevent HIV replication within cells, has successfully passed crucial initial safety tests, bringing hope for a simpler, more accessible form of HIV prevention. According to aidsmap.com researchers involved in the study are optimistic that if subsequent […]